Holders — by stockHoldings — by fund
Deep Track Capital, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001856083
$6.87B
disclosed book value
66
positions
7.4%
largest position share
Positions, as of 2026-06-30
top 67 of 66 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | GHGUARDANT HEALTH INC | 3.4M | $509.1M | 7.4% |
| 2 | IMVTIMMUNOVANT INC | 9.3M | $359.9M | 5.2% |
| 3 | GPCRSTRUCTURE THERAPEUTICS INC | 4.7M | $254.4M | 3.7% |
| 4 | PCVXVAXCYTE INC | 4.3M | $250.0M | 3.6% |
| 5 | ALNYALNYLAM PHARMACEUTICALS INC | 825,000 | $248.3M | 3.6% |
| 6 | MANEVERADERMICS INC | 2.0M | $245.9M | 3.6% |
| 7 | TARSTARSUS PHARMACEUTICALS INC | 3.7M | $230.8M | 3.4% |
| 8 | NUVALENT INC | 1.8M | $220.2M | 3.2% |
| 9 | ALKERMES PLC | 4.0M | $209.6M | 3.1% |
| 10 | OCULOCULAR THERAPEUTIX INC | 19.7M | $193.3M | 2.8% |
| 11 | BMRNBIOMARIN PHARMACEUTICAL INC | 3.3M | $189.3M | 2.8% |
| 12 | NRIXNURIX THERAPEUTICS INC | 7.7M | $187.7M | 2.7% |
| 13 | ORKAORUKA THERAPEUTICS INC | 1.9M | $183.3M | 2.7% |
| 14 | ALMSALUMIS INC | 6.3M | $178.6M | 2.6% |
| 15 | IONSIONIS PHARMACEUTICALS INC | 2.2M | $174.4M | 2.5% |
| 16 | CMPSCOMPASS PATHWAYS PLC | 12.2M | $172.1M | 2.5% |
| 17 | VERAVERA THERAPEUTICS INC | 4.0M | $171.6M | 2.5% |
| 18 | AXSMAXSOME THERAPEUTICS INC. | 700,000 | $171.3M | 2.5% |
| 19 | GMABGENMAB A/S | 5.7M | $155.2M | 2.3% |
| 20 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 7.0M | $136.3M | 2% |
| 21 | COAGHEMAB THERAPEUTICS HLDGS INC | 3.6M | $132.3M | 1.9% |
| 22 | TNGXTANGO THERAPEUTICS INC | 4.2M | $131.3M | 1.9% |
| 23 | DFTXDEFINIUM THERAPEUTICS INC | 2.8M | $129.4M | 1.9% |
| 24 | GRALGRAIL INC | 1.8M | $125.3M | 1.8% |
| 25 | BCAXBICARA THERAPEUTICS INC | 4.1M | $121.7M | 1.8% |
| 26 | MAZEMAZE THERAPEUTICS INC | 3.7M | $111.4M | 1.6% |
| 27 | CLDXCELLDEX THERAPEUTICS INC NEW | 2.9M | $109.4M | 1.6% |
| 28 | LBRXLB PHARMACEUTICALS INC | 3.4M | $108.8M | 1.6% |
| 29 | MBXMBX BIOSCIENCES INC | 1.7M | $95.6M | 1.4% |
| 30 | GH RESEARCH PLC | 3.3M | $89.6M | 1.3% |
| 31 | GMABGENMAB A/SCALL | 3.0M | $82.4M | 1.2% |
| 32 | COGTCOGENT BIOSCIENCES INC | 2.0M | $77.4M | 1.1% |
| 33 | ATAIATAIBECKLEY INC | 14.4M | $76.0M | 1.1% |
| 34 | UTHRUNITED THERAPEUTICS CORP DEL | 123,616 | $67.0M | 1% |
| 35 | AVTXAVALO THERAPEUTICS INC | 3.6M | $66.7M | 1% |
| 36 | VRDNVIRIDIAN THERAPEUTICS INC | 3.6M | $66.0M | 1% |
| 37 | CYTKCYTOKINETICS INC | 700,000 | $59.6M | 0.9% |
| 38 | ALTALTIMMUNE INC | 19.3M | $58.5M | 0.9% |
| 39 | PSNLPERSONALIS INC | 4.0M | $53.6M | 0.8% |
| 40 | ACRSACLARIS THERAPEUTICS INC | 9.3M | $49.4M | 0.7% |
| 41 | CRMDCORMEDIX INC | 6.3M | $49.3M | 0.7% |
| 42 | WGSGENEDX HOLDINGS CORP | 700,000 | $48.1M | 0.7% |
| 43 | HROWHARROW INC | 969,000 | $41.2M | 0.6% |
| 44 | CRVSCORVUS PHARMACEUTICALS INC | 2.5M | $37.2M | 0.5% |
| 45 | SLDBSOLID BIOSCIENCES INC | 3.6M | $35.6M | 0.5% |
| 46 | BEAMBEAM THERAPEUTICS INC | 1.0M | $34.3M | 0.5% |
| 47 | DYNDYNE THERAPEUTICS INC | 1.5M | $33.3M | 0.5% |
| 48 | IMMXIMMIX BIOPHARMA INC | 2.8M | $28.6M | 0.4% |
| 49 | XFORX4 PHARMACEUTICALS INC | 5.9M | $27.5M | 0.4% |
| 50 | STTKSHATTUCK LABS INC | 3.7M | $25.7M | 0.4% |
| 51 | MNKDMANNKIND CORP | 6.0M | $25.6M | 0.4% |
| 52 | IPSCCENTURY THERAPEUTICS INC | 9.5M | $23.2M | 0.3% |
| 53 | GENBGENERATE BIOMEDICINES INC | 1.3M | $22.5M | 0.3% |
| 54 | VSTMVERASTEM INC | 5.7M | $21.9M | 0.3% |
| 55 | KURAKURA ONCOLOGY INC | 2.0M | $21.7M | 0.3% |
| 56 | ENTAENANTA PHARMACEUTICALS INC | 1.4M | $21.1M | 0.3% |
| 57 | NKTRNEKTAR THERAPEUTICS | 300,000 | $20.9M | 0.3% |
| 58 | OLMAOLEMA PHARMACEUTICALS INC | 1.5M | $18.8M | 0.3% |
| 59 | KLRAKAILERA THERAPEUTICS INC | 700,000 | $15.4M | 0.2% |
| 60 | KARDKARDIGAN INC | 600,000 | $14.3M | 0.2% |
| 61 | ELVNENLIVEN THERAPEUTICS INC | 225,000 | $11.4M | 0.2% |
| 62 | PMNPROMIS NEUROSCIENCES INC | 835,655 | $11.0M | 0.2% |
| 63 | IMCRIMMUNOCORE HLDGS PLC | 311,218 | $9.9M | 0.1% |
| 64 | XNCRXENCOR INC | 593,551 | $9.6M | 0.1% |
| 65 | CNTXCONTEXT THERAPEUTICS INC | 7.4M | $4.1M | 0.1% |
| 66 | IVAINVENTIVA SA | 800,000 | $3.0M | 0% |
| 67 | ALGSALIGOS THERAPEUTICS INC | 444,110 | $2.6M | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.